Stable expression of MHC class I heavy chain/HLA-DO complexes at the plasma membrane

European Journal of Immunology

Volumn 33, Issue 5, 2003, Pages 1145-1151

  van Lith, Marcel ^a   van Ham, Marieke ^b   Neefjes, Jacques ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

B cell; Chaperone; Endoplasmic reticulum; HLA DO; MHC class I heavy chain

Indexed keywords

BETA 2 MICROGLOBULIN; CHAPERONE; HLA DM ANTIGEN; HLA DO ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE; TAPASIN;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; BIOSYNTHESIS; CELL MEMBRANE; CELL TRANSPORT; COMPLEX FORMATION; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; GENETIC TRANSFECTION; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNE SYSTEM; NONHUMAN; PRIORITY JOURNAL;

B-LYMPHOCYTES; CELL LINE; HALF-LIFE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-D ANTIGENS; HUMANS; PRECIPITIN TESTS;

EID: 0037960103     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200323472     Document Type: Article

References (17)

1. Karlsson, L., Surh, C. D., Sprent, J. and Peterson, P. A., A novel class II MHC molecule with unusual tissue distribution. Nature 1991. 351: 485-488.
2. Liljedahl, M., Kuwana, T., Fung-Leung, W. P., Jackson, M. R., Peterson, P. A. and Karlsson, L., HLA-DO is a lysosomal resident which requires association with HLA-DM for efficient intracellular transport. EMBO J. 1996. 15: 4817-4824.
3. Douek, D. C. and Altmann, D. M., HLA-DO is an intracellular class II molecule with distinctive thymic expression. Int. Immunol. 1997. 9: 355-364.
4. van Ham, M., van Lith, M., Lillemeier, B., Tjin, E., Gruneberg, U., Rahman, D., Pastoors, L., van Meijgaarden, K., Roucard, C., Trowsdale, J., Ottenhoff, T., Pappin, D. and Neefjes, J., Modulation of the major histocompatibility complex class II-associated peptide repertoire by human histocompatibility leukocyte antigen (HLA)-DO. J. Exp. Med. 2000. 191: 1127-1136.
5. Perraudeau, M., Taylor, P. R., Stauss, H. J., Lindstedt, R., Bygrave, A. E., Pappin, D. J., Ellmerich, S., Whitten, A., Rahman, D., Canas, B., Walport, M. J., Botto, M. and Altmann, D. M., Altered major histocompatibility complex class II peptide loading in H2- O-deficient mice. Eur. J. Immunol. 2000. 30: 2871-2880.
6. Cerundolo, V., Elliott, T., Elvin, J., Bastin, J. and Townsend, A., Association of the human invariant chain with H-2 Db class I molecules. Eur. J. Immunol. 1992. 22: 2243-2248.
7. Sugita, M. and Brenner, M. B., Association of the invariant chain with major histocompatibility complex class I molecules directs trafficking to endocytic compartments. J. Biol. Chem. 1995. 270: 1443-1448.
8. Jayawardena-Wolf, J., Benlagha, K., Chiu, Y. H., Mehr, R. and Bendelac, A., CD1d endosomal trafficking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain. Immunity 2001. 15: 897-908.
9. Kang, S. J. and Cresswell, P., Regulation of intracellular trafficking of human CD1d by association with MHC class II molecules. EMBO J. 2002. 21: 1650-1660.
10. Liljedahl, M., Winqvist, O., Surh, C. D., Wong, P., Ngo, K., Teyton, L., Peterson, P. A., Brunmark, A., Rudensky, A. Y., Fung-Leung, W. P. and Karlsson, L., Altered antigen presentation in mice lacking H2-O. Immunity 1998. 8: 233-243.
11. Denzin, L. K., Sant'Angelo, D. B., Hammond, C., Surman, M. J. and Cresswell, P., Negative regulation by HLA-DO of MHC class II-restricted antigen processing. Science 1997. 278: 106-109.
12. Sernee, M. F., Ploegh, H. L. and Schust, D. J., Why certain antibodies cross-react with HLA-A and HLA-G: epitope mapping of two common MHC class I reagents. Mol. Immunol. 1998. 35: 177-188.
13. Sege, K., Rask, L. and Peterson, P. A., Role of beta2-microglobulin in the intracellular processing of HLA antigens. Biochemistry 1981. 20: 4523-4530.
14. van Lith, M., van Ham, M., Griekspoor, A., Tjin, E., Verwoerd, D., Calafat, J., Janssen, H., Reits, E., Pastoors, L. and Neefjes, J., Regulation of MHC class II antigen presentation by sorting of recycling HLA-DM/DO and class II within the multivesicular body. J. Immunol. 2001. 167: 884-892.
15. Roucard, C., Thomas, C., Pasquier, M. A., Trowsdale, J., Sotto, J. J., Neefjes, J. and van Ham, M., In vivo and in vitro modulation of HLA-DM and HLA-DO is induced by B lymphocyte activation. J. Immunol. 2001. 167: 6849-6858.
16. van Ham, S. M., Tjin, E. P., Lillemeier, B. F., Gruneberg, U., van Meijgaarden, K. E., Pastoors, L., Verwoerd, D., Tulp, A., Canas, B., Rahman, D., Ottenhoff, T. H., Pappin, D. J., Trowsdale, J. and Neefjes, J., HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading. Curr. Biol. 1997. 7: 950-957.
17. Neefjes, J. J., Stollorz, V., Peters, P. J., Geuze, H. J. and Ploegh, H. L., The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route. Cell 1990. 61: 171-183.